by Protein stability analysis refers to examining protein structures and their behavior in solutions under different environmental conditions, over time. It is used to determine how stable a protein is in terms of maintaining its tertiary structure. It helps to ensure the safety and efficacy of biopharmaceutical drugs as well as understand the underlying molecular mechanisms of protein aggregation and amyloid formation linked to certain diseases. The increasing use of protein therapeutics and biologics is driving the need for protein stability analysis.
The Global Protein Stability Analysis Market is estimated to be valued at US$ 2.43 BN in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players operating in the Protein Stability Analysis Market Size are Thermo Fisher Scientific, Inc., Enzo Biochem, Inc., PerkinElmer Inc., NanoTemper, GE Healthcare, HORIBA, Ltd., Malvern Panalytical Ltd., Agilent Technologies, Inc., SETARAM Instrumentation, Unchained Labs, Waters Corporation, and Applied Photophysics Ltd.
Key opportunities: The rising demand for biosimilars and biologics, increasing structural biology research, and growing biotechnology and pharmaceutical industries present lucrative opportunities for players in this market.
Global expansion: Leading companies are expanding their presence globally, especially in emerging markets of Asia Pacific and Latin America, to capitalize on the high growth potential in these regions.
Market drivers: The increasing research and development expenditure on biologics and biosimilars development by pharmaceutical companies is a major market driver. Regulatory policies supporting pharmaceutical research and approvals are also fueling market growth.
PEST Analysis
Political: Regulations around biopharmaceutical safety and efficacy along with rules regarding storage of samples are expected to drive demand to ensure stability and integrity of protein biologics.
Economic: Growth of the biopharmaceutical industry and focus on orphan drugs and personalized medicine will positively impact spending on protein stability testing to facilitate drug development and maintain product quality.
Social: Increasing Research funding and demand for affordable healthcare especially for chronic diseases are leading to focus on development of biotherapeutics which will require protein stability studies.
Technological: Advancements in analysis techniques like DSF, DLS, SPR, chromatography are enabling high throughput stability assessment leading to faster development cycles. Automation and use of robotics along with data analytics is improving efficiency.
Geographical regions with high market concentration
North America dominates the global market in terms of value currently due to presence of major players and robust biopharma industry in the US and Canada. Growing biologics pipeline and large R&D spending contributes to regional share. Europe is second largest with significant research and manufacturing base present across major countries like Germany, UK and France.
Fastest growing region
Asia Pacific region is expected to witness highest growth over the forecast period due to increasing pharmaceutical outsourcing to countries like China and India along with rise of domestic players. Developing biotech hubs, growing biosimilars acceptance and rising contract research activities are spurring regional demand for protein stability analysis solutions to support drug development.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
